Based on current understanding, this is the first meta-analysis to systematically compare multiple CSVD markers (WMHs, CMBs, and lacunes) and genetic risk (APOE ε4) across a range of cognitive outcomes, from MCI through ACD, VaD, AD, and GCI. Here, APOE is linked to Alzheimer disease.